NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $245,000 | +118.8% | 93,684 | +37.8% | 0.00% | – |
| Q4 2018 | $112,000 | -77.3% | 67,969 | -33.4% | 0.00% | – |
| Q3 2018 | $494,000 | +48.3% | 102,038 | +91.4% | 0.00% | – |
| Q2 2018 | $333,000 | -27.1% | 53,302 | -3.2% | 0.00% | – |
| Q1 2018 | $457,000 | -50.8% | 55,041 | -39.5% | 0.00% | -100.0% |
| Q4 2017 | $928,000 | +71.5% | 90,992 | +53.8% | 0.00% | – |
| Q3 2017 | $541,000 | +58.2% | 59,156 | +26.3% | 0.00% | – |
| Q2 2017 | $342,000 | +6.2% | 46,853 | +4.9% | 0.00% | – |
| Q1 2017 | $322,000 | +23.4% | 44,685 | 0.0% | 0.00% | – |
| Q4 2016 | $261,000 | -12.1% | 44,685 | -1.1% | 0.00% | – |
| Q3 2016 | $297,000 | -29.1% | 45,174 | 0.0% | 0.00% | – |
| Q2 2016 | $419,000 | +142.2% | 45,174 | +181.9% | 0.00% | – |
| Q1 2016 | $173,000 | -24.5% | 16,023 | 0.0% | 0.00% | – |
| Q4 2015 | $229,000 | -32.0% | 16,023 | 0.0% | 0.00% | – |
| Q3 2015 | $337,000 | – | 16,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |